http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 07 Feb 2024 02:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/Press+Releases/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html for the full story. http://www.streetinsider.com/PRNewswire/Jazz+Pharmaceuticals+Enters+Definitive+Agreement+with+Redx+Pharma+to+Acquire+Global+Rights+to+KRAS+Inhibitor+Program/22730765.html Wed, 07 Feb 2024 02:00:00 -0500 A.06822034 JAZZ O.08528768 O.12498162 O.20026344 REDX http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Trading+Halts/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Corporate+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Mergers+and+Acquisitions/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Hot+Corp.+News/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html for the full story. http://www.streetinsider.com/Hot+M+and+A/Jounce+Therapeutics+%28JNCE%29+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420185.html Mon, 27 Mar 2023 09:01:10 -0500 JNCE REDX http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html for the full story. http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Mon, 27 Mar 2023 09:00:00 -0500 A.09642568 A.12382694 A.17386746 JNCE O.00832707 O.08528768 O.12252085 O.15504070 O.20371933 REDX http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html for the full story. http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Mon, 27 Mar 2023 09:00:00 -0500 A.09642568 A.12382694 A.17386746 JNCE O.00832707 O.08528768 O.12252085 O.15504070 O.20371933 REDX http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html for the full story. http://www.streetinsider.com/Press+Releases/Jounce+Therapeutics+Enters+Into+Agreement+to+Be+Acquired+by+Concentra+Biosciences+for+%241.85+in+Cash+per+Share+Plus+Contingent+Value+Rights/21420136.html Mon, 27 Mar 2023 09:00:00 -0500 A.09642568 A.12382694 A.17386746 JNCE O.00832707 O.08528768 O.12252085 O.15504070 O.20371933 REDX